Q4 EARNINGS: Teleflex finishes 2013 strongly, but tough 2014 awaits
This article was originally published in Clinica
Executive Summary
Teleflex posted a strong end to fiscal 2013, but its problems aren’t over: “2014 guidance still reflects a challenging healthcare environment,” according to Jefferies analyst Raj Denhoy. The firm’s Q4 sales of $450.5m and earnings of $1.36 per diluted share came in ahead of analyst predictions of $438m and $1.27 per share, respectively.